With no single known cause, no definitive diagnostic test and no cure, ALS remains a tragically confounding neurodegenerative disease. Its progression varies dramatically from patient to patient, leaving clinicians and researchers racing to understand why.
A collaboration between UCSF School of Pharmacy professors Steven Altschuler, PhD, and Lani Wu, PhD, and Catherine Lomen-Hoerth, MD, PhD, director of the ALS Center at UCSF, is developing a new approach to classifying and treating the complexities of ALS by applying high-throughput phenotypic profiling, advanced imaging and real-time patient data analytics.